Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by Current Cardiff authors

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Number of items: 214.

Berni, Ellen, de Voogd, Hanka, Halcox, Julian P, Butler, Christopher C, Bannister, Christian A, Jenkins-Jones, Sara, Jones, Bethan, Ouwens, Mario and Currie, Craig John 2017. Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study. BMJ Open 7 (1) , e013398. 10.1136/bmjopen-2016-013398

Bain, Steve, Druyts, Eric, Balijepalli, Chakrapani, Baxter, Carl A., Currie, Craig J., Das, Romita, Donnelly, Richard, Khunti, Kamlesh, Langerman, Haya, Leigh, Paul, Siliman, Gaye, Thorlund, Kristian, Toor, Kabirraaj, Vora, Jiten and Mills, Edward J. 2016. Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: A Bayesian meta-analysis of survival data. Diabetes, Obesity and Metabolism 19 (3) , pp. 329-335. 10.1111/dom.12821

Orr, James G., Currie, Craig John, Berni, Ellen, Goel, Anurag, Moriarty, Kieran J., Sinha, Ashish, Gordon, Fiona, Dethier, Anne, Dillon, John F., Clark, Katie, Richardson, Paul, Middleton, Paul, Patel, Vishal, Shawcross, Debbie, Preedy, Helen, Aspinall, Richard J. and Hudson, Mark 2016. The impact on hospital resource utilisation of treatment of hepatic encephalopathy with rifaximin-? Liver International 36 (9) , pp. 1295-1303. 10.1111/liv.13111

Berni, Ellen, Scott, Laura A., Jenkins-Jones, Sara, De Voogd, Hanka, Rocha, Monica, Butler, Chris, Morgan, Christopher Ll. and Currie, Craig 2016. Non-Response to Antibiotic Treatment in Adolescents for Four Common Infections in UK Primary Care 1991-2012: A Retrospective, Longitudinal Study. Antibiotics 5 (3) , 25. 10.3390/antibiotics5030025
file

Berni, Ellen, Butler, Chris C., Jenkins-Jones, Sara, de Voogd, Hanka, Ouwens, Mario, Morgan, Christopher Ll. and Currie, Craig John 2016. Comparative estimated effectiveness of antibiotic classes as initial and secondary treatments of respiratory tract infections: longitudinal analysis of routine data from UK primary care 1991-2012. Current Medical Research and Opinion 32 (6) , pp. 1023-1032. 10.1185/03007995.2016.1157459

Akiba, Suminori, Holden, Sarah, Jenkins-Jones, Sara and Currie, Craig John 2016. Association between insulin monotherapy versus insulin plus metformin and the risk of all-cause mortality and other serious outcomes: a retrospective cohort study. PLoS ONE 11 (5) , e0153594. 10.1371/journal.pone.0153594

Bannister, Christian A., Orr, James G., Reynolds, Alan V., Hudson, Mark, Conway, Peter, Radwan, Amr, Morgan, Christopher Ll. and Currie, Craig 2016. Natural history of patients taking Rifaximin-α for recurrent hepatic encephalopathy and risk of future overt episodes and mortality: a post-hoc analysis of clinical trials data. Clinical Therapeutics 38 (5) , pp. 1081-1089. 10.1016/j.clinthera.2016.03.033

Holden, S. E., Currie, Craig John, Lennon, M., Reynolds, A. V. and Moots, R. J. 2016. Cost of dose escalation in people with rheumatoid arthritis treated with tumour necrosis factor inhibitors across Europe. Clinical and Experimental Rheumatology 34 (4) , pp. 679-684.

Stoekenbroek, R.M., Rensing, K.L., Bernelot Moens, S.J., Nieuwdorp, M., DeVries, J.H., Zwinderman, A.H., Stroes, E.S., Currie, Craig and Hutten, B.A. 2015. High daily insulin exposure in patients with type 2 diabetes is associated with increased risk of cardiovascular events. Atherosclerosis 240 (2) , pp. 318-323. 10.1016/j.atherosclerosis.2015.03.040

Holden, Sarah E., Jenkins-Jones, S., Morgan, Christopher L., Schernthaner, G. and Currie, Craig John 2015. Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer. Diabetes, Obesity and Metabolism 17 (4) , pp. 350-362. 10.1111/dom.12412

Holden, Sarah and Currie, Craig 2014. Mortality risk with sulphonylureas compared to metformin. Diabetes, Obesity and Metabolism 16 (10) , pp. 885-890. 10.1111/dom.12280

Currie, Craig and Holden, Sarah 2014. Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin. Diabetes, Obesity and Metabolism 16 (10) , pp. 881-884. 10.1111/dom.12349

Currie, Craig, Berni, Ellen, Jenkins-Jones, Sara, Poole, Chris D., Ouwens, Mario, Driessen, Stefan, de Voogd, Hanka, Butler, Christopher and Morgan, Christopher L.I. 2014. Antibiotic treatment failure in four common infections in UK primary care 1991-2012: longitudinal analysis. BMJ 349 , g5493. 10.1136/bmj.g5493

Holden, Sarah E., Bannister, Christian and Currie, Craig John 2014. Mortality after cancer among patients with diabetes mellitus: effect of diabetes duration and treatment: (questionable) classification of diabetic patients based on combination of specific glucose-lowering drugs. Diabetologia 57 (9) , pp. 2001-2002. 10.1007/s00125-014-3281-1

Holden, Sarah, Gale, E.A.M., Jenkins-Jones, S. and Currie, Craig 2014. How many people inject insulin? UK estimates from 1991 to 2010. Diabetes, Obesity and Metabolism 16 (6) , pp. 553-559. 10.1111/dom.12260

Halcox, Julian P. and Currie, Craig 2014. Lipid-lowering therapy and mortality post-MI: Is it just about the LDL? Heart 100 (11) , pp. 825-826. 10.1136/heartjnl-2014-305556

Morgan, Christopher, Puelles, Jorge, Poole, Chris D. and Currie, Craig 2014. The effect of withdrawal of rosiglitazone on treatment pathways, diabetes control and patient outcomes: a retrospective cohort study. Journal of Diabetes and its Complications 28 (3) , pp. 360-364. 10.1016/j.jdiacomp.2014.01.007

Bannister, Christian, Currie, Craig John, Preece, Alun David and Spasic, Irena 2014. Automatic development of clinical prediction models with genetic programming: A case study in cardiovascular disease. Value in Health 17 (3) , A200-A201. 10.1016/j.jval.2014.03.1171

Bannister, Christian, Poole, Christopher David, Jenkins-Jones, Sara, Morgan, Christopher L., Elwyn, Glyn, Spasic, Irena and Currie, Craig John 2014. External validation of the UKPDS risk engine in incident type 2 diabetes: a need for new type 2 diabetes-specific risk equations. Diabetes Care 37 (2) , pp. 537-545. 10.2337/dc13-1159
file

Orr, J., Morgan, Christopher, Hudson, M., Jenkins-Jones, S., Conway, P., Radwan, A. and Currie, Craig 2014. PTU-127 Resource use associated with Hepatic Encephalopathy in patients with severe liver disease. Gut 63 (Suppl) , A94. 10.1136/gutjnl-2014-307263.201

Morgan, Christopher, Jenkins-Jones, S., Radwan, A., Conway, P. and Currie, Craig 2014. PTU-126 Mortality associated with hepatic encephalopathy in patients with severe liver disease. Gut 63 (Suppl) , A94. 10.1136/gutjnl-2014-307263.200

Poole, Christopher David, Bannister, Christian, Andreasen, Jakob, Andersen, Jens and Currie, Craig John 2014. Estimation of health-related utility (EQ-5D index) in subjects with seasonal allergic rhinoconjunctivitis to evaluate health gain associated with sublingual grass allergen immunotherapy. Health and Quality of Life Outcomes 12 (1) , 99. 10.1186/1477-7525-12-99
file

Poole, Christopher David, Conway, P., Nanuwa, K., Joseph, B., Bannister, Christian and Currie, Craig John 2014. P451 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy. Journal of Hepatology 60 (1) , S219. 10.1016/S0168-8278(14)60613-9

Berni, E, Bannister, Christian, Poole, Christopher David, Conway, P., Nanuwa, K. and Currie, Craig John 2014. PWE-154 the first evaluation of the relationship between the chronic liver disease questionnaire and the Eq-5d index In hepatic encephalopathy patients treated with Rifaximin-a. Gut 63 (Suppl) , A192. 10.1136/gutjnl-2014-307263.414

Poole, Christopher David, Conway, P., Nanuwa, K., Joseph, B., Bannister, Christian and Currie, Craig John 2014. PWE-153 cost effectiveness of Rifaximin-a in the reduction of recurrence of overt hepatic encephalopathy. Gut 63 (Suppl) , A191. 10.1136/gutjnl-2014-307263.413

Holden, Sarah, Barnett, A.H., Peters, J.R., Jenkins-Jones, S., Poole, C.D., Morgan, Christopher and Currie, Craig 2013. The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010. Diabetes, Obesity and Metabolism 15 (9) , pp. 844-852. 10.1111/dom.12123

Bannister, Christian, Poole, Christopher David, Jenkins-Jones, Sara, Morgan, Christopher L., Currie, Craig and Elwyn, Glyn 2013. Orals: validation of UKPDS risk engine predictions among patients with type 2 diabetes routinely managed in UK primary care. Diabetes 62 (Supp 1) , A71-A71. 10.2337/db13-1-387

Currie, Craig John, Peyrot, Mark, Morgan, Christopher L, Poole, C., Jenkins-Jones, S., Rubin, Richard R., Burton, Christopher M. and Evans, Marc 2013. The impact of treatment non-compliance on mortality in people with type 1 diabetes. Journal of Diabetes and its Complications 27 (3) , pp. 219-223. 10.1016/j.jdiacomp.2012.10.006

Currie, Craig John, Poole, Christopher David, Evans, Marc, Peters, John Redmond and Morgan, Christopher L. 2013. Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes. Journal of Clinical Endocrinology & Metabolism 98 (2) , pp. 668-677. 10.1210/jc.2012-3042
file

Morgan, Christopher L., Poole, Christopher David, Evans, Marc, Barnett, Anthony H., Jenkins-Jones, Sara and Currie, Craig John 2012. What next after metformin? A retrospective evaluation of the outcome of second-line, glucose-lowering therapies in people with type 2 diabetes. Journal of Clinical Endocrinology & Metabolism 97 (12) , p. 4605. 10.1210/jc.2012-3034

Morgan, Christopher L., Jenkins-Jones, Sara, Currie, Craig John and Rees, Dafydd Aled 2012. Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. Journal of Clinical Endocrinology & Metabolism 97 (9) , pp. 3251-3260. 10.1210/jc.2012-1690

Currie, Craig John 2012. ADVANCE and glycaemia thresholds: a need to clarify the statistical approach [Letter]. Diabetologia 55 (8) , pp. 2298-2299. 10.1007/s00125-012-2575-4

Currie, Craig John, Peyrot, M., Morgan, Christopher L., Poole, Christopher David, Jenkins-Jones, Sara, Rubin, Richard R., Burton, Christopher M. and Evans, Marc 2012. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 35 (6) , pp. 1279-1284. 10.2337/dc11-1277

Poole, Christopher David, Morgan, Christopher L., Conway, P. and Currie, Craig John 2012. PSU1 Adverse events commonly associated with opioid use: impact upon length of stay following surgical procedure [Abstract]. Value In Health 15 (4) , A73. 10.1016/j.jval.2012.03.404

Poole, Christopher David, Currie, Craig John, Holden, Sarah E. and Singh, A. 2012. PMS19 Impact of disease severity on the total, health-related, financial costs of treatment of people with rheumatoid arthritis in the United Kingdom [Abstract]. Value In Health 15 (4) , A36-A37. 10.1016/j.jval.2012.03.208

Morgan, Christopher L., Jenkins-Jones, Sara, Evans, Meirion Rhys, Barnett, A. H., Poole, Christopher David and Currie, Craig John 2012. Weight change in people with type 2 diabetes: secular trends and the impact of alternative antihyperglycaemic drugs. Diabetes, Obesity and Metabolism 14 (5) , pp. 424-432. 10.1111/j.1463-1326.2011.01552.x

Holden, Sarah E. and Currie, Craig John 2012. Endogenous hyperinsulinaemia and exogenous insulin: a common theme between atherosclerosis, increased cancer risk and other morbidities. Atherosclerosis 222 (1) , pp. 26-28. 10.1016/j.atherosclerosis.2012.01.052

Currie, Craig John, Poole, Christopher David, Jenkins-Jones, Sara, Gale, E. A. M., Johnson, J. A. and Morgan, Christopher L. 2012. Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival. Diabetes Care 35 (2) , pp. 299-304. 10.2337/dc11-1313

Currie, Craig John and Johnson, J. A. 2012. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Diabetes, Obesity and Metabolism 14 (1) , pp. 1-4. 10.1111/j.1463-1326.2011.01469.x

Holden, Sarah E., Poole, Christopher David, Morgan, Christopher L. and Currie, Craig John 2011. Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin. British Medical Journal Open 1 (2) , e000258. 10.1136/bmjopen-2011-000258
file

Morgan, Christopher L., Evans, Marc, Toft, Anders D., Jenkins-Jones, Sara, Poole, Christopher David and Currie, Craig John 2011. Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study. Clinical Therapeutics 33 (1) , pp. 27-35. 10.1016/j.clinthera.2011.01.023

Morgan, Christopher Ll., Conway, Pete and Currie, Craig John 2011. The relationship between self-reported severe pain and measures of socio-economic disadvantage. European Journal of Pain 15 (10) , pp. 1107-1111. 10.1016/j.ejpain.2011.04.010

Dixon, Simon, Poole, Christopher David, Odeyemi, Isaac, Retsa, Peny, Chambers, Colette and Currie, Craig John 2011. Deriving health state utilities for the numerical pain rating scale. Health and Quality of Life Outcomes 9 , pp. 96-104. 10.1186/1477-7525-9-96
file

Poole, Christopher David, Singh, A., Freundlich, B., Koenig, A. and Currie, Craig John 2010. PMS2 Estimating health-based utility from clinically assessed disease severity in ankylosing spondylitis [Abstract]. Value in Health 13 (3) , A122. 10.1016/S1098-3015(10)72590-0

Poole, Christopher David, Chambers, C., Allsopp, R. and Currie, Craig John 2010. Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids. Journal of the European Academy of Dermatology and Venereology 24 (6) , pp. 674-678. 10.1111/j.1468-3083.2009.03485.x

Currie, Craig John, Poole, Christopher David, Singh, A. and Reynolds, A. 2010. PMS17 Estimation of costs of health care for people with rheumatoid arthritis for varying degrees of disability as measured by the health assessment questionnaire in the United Kingdom [Abstract]. Value in Health 13 (3) , A125. 10.1016/S1098-3015(10)72605-X

Poole, Christopher David, Evans, Louise Marie, Peters, John Redmond and Currie, Craig John 2010. PDB10 Survival as a function of HBA1C in people with type 2 diabetes: a retrospective cohort study [Abstract]. Value in Health 13 (3) , A56. 10.1016/S1098-3015(10)72257-9

Currie, Craig John and Poole, Christopher David 2010. Survival as a function of HbA1c in people with type 2 diabetes – Authors' reply. The Lancet 375 (9724) , pp. 1434-1435. 10.1016/S0140-6736(10)60616-2

Currie, Craig John, Gale, E. A. and Poole, Christopher David 2010. PCN16 Cancer incidence is influenced by insulin dose and metformin in type 2 diabetes [Abstract]. Value in Health 13 (3) , A26. 10.1016/S1098-3015(10)72107-0

Morgan, Christopher L., Poole, Christopher David, Jenkins-Jones, Sara, Evans, Louise Marie and Currie, Craig John 2010. PDB15 Weight change for patients with type 2 diabetes: secular trends and impact of different combinations of therapy [Abstract]. Value in Health 13 (7) , A286. 10.1016/S1098-3015(11)72073-3

Poole, Christopher David, Connolly, Mark P., Nielsen, Sandy Kildegaard, Currie, Craig John and Marteau, Philippe 2010. A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis. Journal of Crohn's and Colitis 4 (3) , pp. 275-282. 10.1016/j.crohns.2009.11.010

Currie, Craig John, Peters, John Redmond, Tynan, Aodán, Evans, Marc, Heine, Robert J., Bracco, Oswaldo L., Zagar, Tony and Poole, Christopher David 2010. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. The Lancet 375 (9713) , pp. 481-489. 10.1016/S0140-6736(09)61969-3

Poole, Christopher David, Lebmeier, M., Ara, R., Rafia, R. and Currie, Craig John 2010. Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK. Rheumatology 49 (10) , pp. 1949-1956. 10.1093/rheumatology/keq182

Currie, Craig John, Peters, J. R. and Evans, M. 2010. Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008. Diabetic Medicine 27 (7) , pp. 744-752. 10.1111/j.1464-5491.2009.02849.x

Morgan, Christopher L., Peters, J. R. and Currie, Craig John 2010. The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK. Diabetic Medicine 27 (6) , pp. 673-678. 10.1111/j.1464-5491.2010.02912.x

Currie, Craig John, Gale, E. A. M. and Poole, Christopher David 2010. Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007. Diabetic Medicine 27 (8) , pp. 938-948. 10.1111/j.1464-5491.2010.03040.x

Morgan, Christopher L., Peters, J. R., Dixon, S. and Currie, Craig John 2010. Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region. Diabetic Medicine 27 (9) , pp. 1066-1073. 10.1111/j.1464-5491.2010.03086.x

Currie, Craig John, Poole, Christopher David and Gale, E. A. M. 2009. The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52 (9) , pp. 1766-1777. 10.1007/s00125-009-1440-6

Currie, Craig John, Poole, Christopher David and Papo, P. L. 2009. PDB64 A review of retrospective, continuous glucose monitoring: an example of a medical device where the typical primary outcome measure may be inappropriate? [Abstract]. Value in Health 12 (3) , A109. 10.1111/j.1524-4733.2009.00537_2.x

Poole, Christopher David, Chambers, C., Allsopp, Richard and Currie, Craig John 2009. PSS15 Changes in health related utility among adults with atopic dermatitis treated with tacrolimus ointment compared to a standard corticosteroid regimen [Abstract]. Value in Health 12 (3) , A77. 10.1111/j.1524-4733.2009.00537_2.x

Currie, Craig John 2009. The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings [Letter]. Diabetologia 52 (10) , pp. 2234-2235. 10.1007/s00125-009-1477-6

Connolly, Mark P., Nielsen, Sandy K., Currie, Craig John, Poole, Christopher David and Travis, Simon P. L. 2009. An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial. Journal of Crohn's and Colitis 3 (1) , pp. 32-37. 10.1016/j.crohns.2008.10.004

Connolly, Mark P., Nielsen, Sandy K., Currie, Craig John, Marteau, Philippe, Probert, Chris S. J. and Travis, Simon P. L. 2009. An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial. Journal of Crohn's and Colitis 3 (3) , pp. 168-174. 10.1016/j.crohns.2009.02.005

Poole, C. D., Chambers, C., Sidhu, M. K. and Currie, Craig John 2009. Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic CONTROL study. British Journal of Dermatology 161 (6) , pp. 1335-1340. 10.1111/j.1365-2133.2009.09379.x

Currie, Craig John, Poole, Christopher David and Papo, Natalie L. 2009. An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes. Current Medical Research and Opinion 25 (10) , pp. 2389-2400. 10.1185/03007990903094452

Poole, Christopher David, Sidhu, M. and Currie, Craig John 2008. PSS39 Estimating health related utility from symptom severity in atopic dermatitis (eczema) [Abstract]. Value in Health 11 (3) , A296. 10.1016/S1098-3015(10)70934-7

Currie, Craig John, Sidhu, M. and Poole, Christopher David 2008. PSS37 Mapping the dermatology quality of life index (DLQI) to health-related utility via the SF-12 in subjects with eczema [Abstract]. Value in Health 11 (3) , A295-A296. 10.1016/S1098-3015(10)70932-3

Poole, Christopher David, Nielsen, S. K., Currie, Craig John and Connolly, M. 2008. PGI25 Establishing the relationship between the ulcerative colitis disease activity instrument(UCDAI) and patient health related quality of life from a large randomised controlled trial [Abstract]. Value in Health 11 (6) , A526. 10.1111/j.1524-4733.2008.00453_2.x

Conway, P., Dixon, S. and Currie, Craig John 2008. PSS54 Evaluation of treatment satisfaction with etanercept versus alternative treatments for psoriasis: a patient survery across nine European countries [Abstract]. Value in Health 11 (6) , A626. 10.1111/j.1524-4733.2008.00453_2.x

Connolly, M., Nielsen, S. K., Currie, Craig John and Poole, Christopher David 2008. PGI10 Once daily mesalazine for maintaining remission is cost-saving compared to twice daily mesalazine: an economic evaluation based on the podium randomised controlled trial [Abstract]. Value in Health 11 (6) , A521. 10.1111/j.1524-4733.2008.00453_2.x

Poole, Christopher David, Nielsen, S. K., Currie, Craig John and Connolly, M. 2008. PGI23 Quality of life (health-related utility) in adults with ulcerative colitis in remission vs. mild/moderate and severe relapse: findings from the podium study [Abstract]. Value in Health 11 (6) , A525. 10.1111/j.1524-4733.2008.00453_2.x

Conway, P. and Currie, Craig John 2008. PSS36 The descriptive epidemiology and outcome of hospitalisations for psoriasis in the United Kingdom [Abstract]. Value in Health 11 (6) , A620. 10.1111/j.1524-4733.2008.00453_2.x

Connolly, Mark, De Vrieze, Kathleen, Ombelet, Willem, Schneider, Dirk and Currie, Craig J. 2008. A cost per live birth comparison of HMG and rFSH randomized trials. Reproductive BioMedicine Online 17 (6) , pp. 756-763. 10.1016/S1472-6483(10)60402-6

Currie, Craig John 2008. CHKS data should be avoided when investigating mortality [Letter]. Respiratory Medicine 102 (1) , p. 172. 10.1016/j.rmed.2007.07.026

Poole, Christopher David, Conway, P. and Currie, Craig John 2008. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology 48 (1) , pp. 78-82. 10.1093/rheumatology/ken415

Alcolado, J., Poole, Christopher David, Peters, John Redmond and Currie, Craig John 2008. Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues. Diabetic Medicine 25 (1) , pp. 115-116. 10.1111/j.1464-5491.2007.02335.x

Conway, Pete and Currie, Craig John 2008. Descriptive epidemiology of hospitalisation for psoriasis. Current Medical Research and Opinion 24 (12) , pp. 3487-3491. 10.1185/03007990802583563

Poole, C. D., Conway, P. and Currie, Craig John 2007. An evaluation of the association between systemic inflammation--as measured by C-reactive protein--and hospital resource use. Current Medical Research and Opinion 23 (11) , pp. 2785-2792. 10.1185/030079907x233205

Currie, Craig John, Conway, P. and Poole, C. D. 2007. Ischaemic heart disease in men [letter]. Heart -London- BMJ Publishing Group 93 (11) , pp. 1471-1472. 10.1136/hrt.2007.130567

Currie, Craig John, Poole, Christopher David, Tynan, A. and Simpson, A. 2007. An evaluation of treatment discontinuation patterns in people with type 1 and type 2 diabetes switched to alternative short acting insulin. Value in Health 10 (6) , A270. 10.1016/s1098-3015(10)65001-2

Nielsen, S. K., Currie, Craig John, Connolly, M. P. and Bhatt, A. 2007. Evaluation of improvement in health-related quality of life using oral mesalazine alone or in combination with a mesalazine enema. Value in Health 10 (6) , A230. 10.1016/s1098-3015(10)64879-6

Currie, Craig John and Conway, P. 2007. Evaluation of the association between EQ5D utility and dermatology life quality index (DLQI) score in patients with psoriasis. Value in Health 10 (6) , A470-A471. 10.1016/s1098-3015(10)65617-3

Poole, C., Tynan, A. and Currie, Craig John 2007. Evaluation of the association between glucose variability,as measured by the difference between maximum and minimum, intermittent,random blood glucose observations, and long term clinical outcome in subjects with type 2 diabetes treated with insulin. Value in Health 10 (6) , A255-A256. 10.1016/s1098-3015(10)64956-x

Currie, Craig John and Conway, P. 2007. Evaluation of the association between psoriasis severity and hospital resource use in the United Kingdom. Value in Health 10 (6) , A469. 10.1016/s1098-3015(10)65613-6

Nieslen, S. K., Connolly, M. P., Bhatt, A. and Currie, Craig John 2007. Evaluation of the cost-effectiveness of concomitant oral and topical mesalazine treatment versus oral treatment alone in mild-to-moderate. Value in Health 10 (6) , A353. 10.1016/s1098-3015(10)65255-2

Poole, C., Agrawal, S. and Currie, Craig John 2007. Let cost effectiveness models be open to scrutiny [letter]. BMJ 335 (7623) , p. 735. 10.1136/bmj.39360.379664.be

Currie, Craig John 2007. Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues? [editorial]. Diabetic Medicine 24 (10) , pp. 1058-1059. 10.1111/j.1464-5491.2007.02284.x

Freemantle, N., Stella, P., Munro, V., Currie, Craig John and Poole, C. 2007. Comment and Reply on:Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir [letter]. Current Medical Research and Opinion 23 (8) , pp. 1761-1764. 10.1185/030079907x210813

Wechowski, Jaroslaw, Connolly, Mark, Woehl, Anette, Tetlow, Anthony, McEwan, Phil, Burroughs, Andrew, Currie, Craig John and Bhatt, Aomesh 2007. An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis. Current Medical Research and Opinion 23 (7) , pp. 1481-1491. 10.1185/030079907X199736

Currie, Craig John, Poole, Christopher David, Woehl, Anette, Morgan, Christopher L., Cawley, S., Rousculp, M. D., Covington, M. T. and Peters, John Redmond 2007. The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy. Diabetic Medicine 24 (2) , pp. 187-194. 10.1111/j.1464-5491.2006.02057.x

McEwan, Phil, Poole, Chris D., Tetlow, Tony, Holmes, Paul and Currie, Craig John 2007. Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK. Current Medical Research and Opinion 23 (s1) , S21-S31. 10.1185/030079907X167570

McEwan, Phil, Poole, Chris D., Tetlow, Tony, Holmes, Paul and Currie, Craig John 2007. Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK. Current Medical Research and Opinion 23 (s1) , S7-S19. 10.1185/030079906X167561

Currie, Craig John, Poole, Chris D., Tetlow, Tony, Holmes, Paul and McEwan, Phil 2007. The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis. Current Medical Research and Opinion 23 (s1) , S33-S39. 10.1185/030079907X167534

Poole, Chris D., Tetlow, Tony, McEwan, Phil, Holmes, Paul and Currie, Craig John 2007. The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis. Current Medical Research and Opinion 23 (s1) , S41-S48. 10.1185/030079907X167589

Currie, Craig John, Evans, M. and Poole, Christopher David 2007. Letter [Letter]. Diabetes, Obesity and Metabolism 10 (1) , pp. 94-95. 10.1111/j.1463-1326.2007.00829.x

Currie, Craig John, Poole, Christopher David and Conway, P. 2007. Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality. Heart 94 (4) , pp. 457-462. 10.1136/hrt.2007.118794

Currie, Craig John 2006. Diabetes prevalence in England, 2001 [Letter]. Diabetic Medicine 23 (11) , p. 1268. 10.1111/j.1464-5491.2006.1938_1.x

Currie, Craig John, Tetlow, A. P., Holmes, P., Poole, Christopher David and McEwan, Philip Christopher 2006. An evaluation of diabetes control and reports of hypoglycaemia in UK general practice following initiation of insulin glargine versus insulin detemir using observational, real-life data [Abstract]. Value in Health 9 (6) , A224. 10.1016/S1098-3015(10)63272-X

Poole, Christopher David, Tetlow, A. P., Holmes, P., McEwan, Philip Christopher and Currie, Craig John 2006. An evaluation of the cost of diabetes-related medication following initiation of treatment with insulin glargine versus insulin detemir in the UK from observational, real-life data from general practice [Abstract]. Value in Health 9 (6) , A224-A225. 10.1016/S1098-3015(10)63274-3

Wechowski, J. G., Tetlow, A. P., McEwan, Philip Christopher, Woehl, Anette and Currie, Craig John 2006. Cost-utility analysis in a UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients - a discrete event simulation model [Abstract]. Value in Health 9 (6) , A190. 10.1016/S1098-3015(10)63165-8

Woehl, Anette and Currie, Craig John 2006. The relationship between weight changes and related changes in health-related utility: evidence of cause and affect [Abstract]. Value in Health 9 (6) , A326. 10.1016/S1098-3015(10)63585-1

McEwan, Philip Christopher, Poole, Christopher David, Holmes, P., Tetlow, A. P. and Currie, Craig John 2006. The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes [Abstract]. Value in Health 9 (6) , A225-A226. 10.1016/S1098-3015(10)63277-9

McEwan, Philip Christopher, Tetlow, A. P., Holmes, P., Poole, Christopher David and Currie, Craig John 2006. The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 2 diabetes [Abstract]. Value in Health 9 (6) , A227-A228. 10.1016/S1098-3015(10)63283-4

Morgan, Christopher L., McEwan, P., Morrissey, M., Peters, J. R., Poole, C. and Currie, Craig John 2006. Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications. Diabetic Medicine 23 (10) , pp. 1100-1105. 10.1111/j.1464-5491.2006.01936.x

Currie, Craig John, Poole, Christopher David, Woehl, Anette, Morgan, Christopher L., Cawley, S., Rousculp, M. D., Covington, M. T. and Peters, John Redmond 2006. The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy. Diabetologia 49 (10) , pp. 2272-2280. 10.1007/s00125-006-0380-7

Currie, Craig John, Morgan, Christopher L., Poole, Chris D., Sharplin, Peter, Lammert, Morten and McEwan, Phil 2006. Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes. Current Medical Research and Opinion 22 (8) , pp. 1523-1534. 10.1185/030079906X115757

Currie, Craig John and Wechowski, Jaroslaw G. 2006. Randomized single versus double embryo transfer studies: obstetric and paediatric outcome and a cost-effectiveness analysis [Letter]. Human Reproduction 21 (7) , pp. 1939-1940. 10.1093/humrep/del095

Currie, Craig John, McEwan, Philip Christopher, Poole, Christopher David, Odeyemi, Isaac A. O., Datta, Shibendra N. and Morgan, Christopher L. 2006. The impact of the overactive bladder on health-related utility and quality of life. BJU International 97 (6) , pp. 1267-1272. 10.1111/j.1464-410X.2006.06141.x

Currie, Craig John, McEwan, Phil, Poole, Chris, Valentine, William J., Palmer, Andrew J., Lammert, Morten, Nicklasson, Lars, Foos, Volker and Roze, Stéphane 2006. Comments on Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting [Letter]. Current Medical Research and Opinion 22 (5) , pp. 967-969. 10.1185/030079906X00000

Woehl, Anette, Morgan, Christopher L. and Currie, Craig John 2006. Long term survival as a function of airway obstruction (FEV1) in subjects with chronic obstructive pulmonary disease: A population based record linkage study in a large UK population [Abstract]. Value in Health 9 (3) , A7-A7.

McEwan, P., Bergenheim, K. and Currie, Craig John 2006. External validation of the UKPDS Outcomes Model equations (UKPDS 68), and the UKPDS risk engine equations (UKPDS 56 and 60) in forecasting cardiovascular outcomes in people with type 2 diabetes [Abstract]. Value in Health 9 (3) , A37-A38.

Wechowski, J. G., Poole, C. D. and Currie, Craig John 2006. The short term cost-effectiveness of 45 surgical interventions in the UK [Abstract]. Value in Health 9 (3) , A173-A173.

Currie, Craig John, Jones, M., Goodfellow, J., McEwan, P., Morgan, Christopher L., Emmas, C. and Peters, J. R. 2006. Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin. Heart 92 (2) , pp. 196-200. 10.1136/hrt.2004.058339

McEwan, Phil, Dixon, Simon, Baboolal, Keshwar, Conway, Pete and Currie, Craig John 2006. Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK. PharmacoEconomics 24 (1) , pp. 67-79. 10.2165/00019053-200624010-00006

Palmer, Andrew J. and Currie, Craig John 2006. Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes [Correspondence]. PharmacoEconomics 24 (9) , pp. 927-929. 10.2165/00019053-200624090-00009

Currie, Craig John, McEwan, Phil, Emmas, Cathy, Morgan, Christopher L. and Peters, John R. 2005. Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population. Current Medical Research and Opinion 21 (12) , pp. 1905-1913. 10.1185/030079905X75050

Currie, Craig, Cawley, S., Morgan, Christopher L., McEwan, P., Price, Patricia Elaine, Covington, M. and Peters, J. R. 2005. Diabetic peripheral neuropathy: evaluation of the inter-association between the ranges of neuropathic symptoms. Value In Health 8 (6) , A154-A154.

Currie, Craig, Cawley, S., Morgan, Christopher L., McEwan, P., Price, Patricia Elaine, Peters, J. R. and Covington, M. 2005. Diabetic peripheral neuropathy: evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health care resource use and productive losses. Value In Health 8 (6) , A167-A167.

Currie, Craig, Covington, M., McEwan, P., Price, Patricia Elaine, Morgan, Christopher L., Cawley, S. and Peters, J. R. 2005. Diabetic peripheral neuropathy: evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health related utility (EQ5D). Value In Health 8 (6) , A172-A173.

Lee, Amanda J., Morgan, Christopher L., Conway, Pete and Currie, Craig John 2005. Characterisation and comparison of health-related quality of life for patients with renal failure. Current Medical Research and Opinion 21 (11) , pp. 1777-1783. 10.1185/030079905X65277

McEwan, Phil, Baboolal, Keshwar, Dixon, Simon, Conway, Pete and Currie, Craig John 2005. Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years. Current Medical Research and Opinion 21 (11) , pp. 1793-1800. 10.1185/030079905X65574

Lee, A. J., Morgan, Christopher L., Morrissey, M., Wittrup-Jensen, K. U., Kennedy-Martin, T. and Currie, Craig John 2005. Evaluation of the association between the EQ-5Dindex (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes. Diabetic Medicine 22 (11) , pp. 1482-1486. 10.1111/j.1464-5491.2005.01657.x

McEwan, Phil, Baboolal, Keshwar, Conway, Pete and Currie, Craig John 2005. Evaluation of the cost-effectiveness of Sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom. Clinical Therapeutics 27 (11) , pp. 1834-1846. 10.1016/j.clinthera.2005.11.002

Cockcroft, John Ronald, Wilkinson, Ian B., Evans, Marc, McEwan, Philip Christopher, Peters, John Redmond, Davies, Steve, Scanlon, Maurice Francis and Currie, Craig John 2005. Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus. American Journal of Hypertension 18 (11) , pp. 1463-1467. 10.1016/j.amjhyper.2005.05.009

Currie, Craig John, McEwan, P., Emmas, C. and Peters, J. R. 2005. Anticoagulation in patients with non-valvular atrial fibrillation: An evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population [Abstract]. Value in Health 8 (6) , A91-A92.

Savani, V., Currie, Craig John, Griffin, J., Loftus, J. and McEwan, P. 2005. Chronic obstructive pulmonary disease: A comparison of estimates of health-related utility (EQ5D) from SF36 data alone, the SF36 plus lung function data, and the SF36 plus the St. George's Respiratory Questionnaire plus lung function data [Abstract]. Value in Health 8 (6) , A216-A216.

Currie, Craig John, Covington, M., McEwan, P., Price, P., Morgan, Christopher L., Cawley, S. and Peters, J. R. 2005. Diabetic peripheral neuropathy: Evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health-related utility (EQ5D) [Abstract]. Value in Health 8 (6) , A172-A173.

Currie, Craig John, Cawley, S., Morgan, Christopher L., McEwan, P., Price, P., Peters, J. R. and Covington, M. 2005. Diabetic peripheral neuropathy: Evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health care resource use and productive losses [Abstract]. Value in Health 8 (6) , A167-A167.

Currie, Craig John, Cawley, S., Morgan, Christopher L., McEwan, P., Price, P., Covington, M. and Peters, J. R. 2005. Diabetic peripheral neuropathy: Evaluation of the inter-association between the ranges of neuropathic symptoms [Abstract]. Value in Health 8 (6) , A154-A154.

Woehl, Anette, Peters, John Redmond, McEwan, Philip Christopher and Currie, Craig John 2005. Evaluation of the association between Body Mass Index, waist circumference and health-related utility (EQ5D) [Abstract]. Value in Health 8 (6) , A76-A77. 10.1016/S1098-3015(10)67377-9

Poole, Christopher David, Odeyemi, I. A., McEwan, Philip Christopher and Currie, Craig John 2005. The impact of the overactive bladder on quality of life (SF36) and utility (EQ5D) [Abstract]. Value in Health 8 (6) , A85. 10.1016/S1098-3015(10)67402-5

Ray, J., Palmer, A. J., Tucker, D. M., Valentine, W. J., Currie, Craig, McEwan, P. and Brandle, M. 2005. Insulin pumps: more consultation was needed [LETTER]. BMJ 331 (7521) , pp. 905-906. 10.1136/bmj.331.7521.905-c

Davis, Ruth E., Morrissey, Malcolm, Peters, John R., Wittrup-Jensen, Kim, Kennedy-Martin, Tessa and Currie, Craig John 2005. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Current Medical Research and Opinion 21 (9) , pp. 1477-1483. 10.1185/030079905X61929

Currie, Craig John, McEwan, Phil, Peters, John R., Patel, Tunia C. and Dixon, Simon 2005. The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects. Value in Health 8 (5) , pp. 581-590. 10.1111/j.1524-4733.2005.00046.x

Woehl, Anette and Currie, Craig John 2005. Estimation of the financial impact of obesity on the National Health Service and society in the United Kingdom [Abstract]. Value in Health 8 (3) , p. 250. 10.1016/S1098-3015(10)62609-5

Woehl, Anette, Davies, S., Scanlon, Maurice Francis and Currie, Craig John 2005. Evaluation of the association between height and health-related utility (EQ5DINDEX) [Abstract]. Value in Health 8 (3) , pp. 280-281. 10.1016/S1098-3015(10)62705-2

Currie, Craig John, Griffiths, T., Gosden, T., Morrissey, Malcolm Ivor, Patel, Tunia C. and McEwan, Philip Christopher 2005. Evaluation of the association between severity of chronic obstructive pulmonary disease (COPD) with health-related utility (EQ5DINDEX) and health care resource use [Abstract]. Value in Health 8 (3) , p. 326. 10.1016/S1098-3015(10)62854-9

McEwan, P., Peters, J. R. and Currie, Craig John 2005. Evaluation of the clinical outcome and financial costs of delaying the onset of frank type-2 diabetes [Abstract]. Value in Health 8 (3) , p. 355.

Peters, J. R., Morrissey, Malcolm Ivor, Morgan, Christopher L., Piper, E., Sharplin, P. and Currie, Craig John 2005. Evaluation of the impact on the EQ5DINDEX (heath-related utility) of conversion to insulin glargine (lantus) following failure on oral agents in people with type-2 diabetes: Interim analysis [Abstract]. Value in Health 8 (3) , p. 359.

Woehl, Anette and Currie, Craig John 2005. Recent trends and a future forecast of population body mass index levels in the United Kingdom [Abstract]. Value in Health 8 (3) , p. 406. 10.1016/S1098-3015(10)63104-X

Woehl, Anette, Currie, Craig John, McEwan, Philip Christopher and Peters, John Redmond 2005. Reliable measurement of obesity: risk of vascular disease complications as a function of body mass index and waist-to-hip ratio [Abstract]. Value in Health 8 (3) , pp. 406-407. 10.1016/S1098-3015(10)63106-3

Currie, Craig John and McEwan, Philip Christopher 2005. The UK EQ-5D index: an evaluation of face validity in hospital treated subjects [Abstract]. Value in Health 8 (3) , pp. 379-380. 10.1016/S1098-3015(10)63020-3

Jones, M., McEwan, P., Morgan, Christopher L., Peters, J. R., Goodfellow, J. and Currie, Craig John 2005. Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population. Heart 91 (4) , pp. 472-477. 10.1136/hrt.2004.042465

Currie, Craig John, Morgan, Christopher Llewellyn, Dixon, Simon, McEwan, Philip Christopher, Marchant, Nick, Bearne, Andy, Sharplin, Peter and Peters, John Redmond 2005. The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications. Diabetes Research and Clinical Practice 67 (2) , pp. 144-151. 10.1016/j.diabres.2004.01.002

Dixon, Simon, Currie, Craig John and McEwan, Phil 2004. Utility values for obesity and preliminary analysis of the Health Outcomes Data Repository [Review]. Expert Review of Pharmacoeconomics & Outcomes Research 4 (6) , pp. 657-665. 10.1586/14737167.4.6.657

McEwan, Philip Christopher, Peters, John Redmond and Currie, Craig John 2004. Evaluation of improved utility estimates in cost effectiveness analysis of multiple complications in type-2 diabetes [Abstract]. Value in Health 7 (6) , p. 735. 10.1016/S1098-3015(10)65945-1

Jones, M., Currie, Craig John and McEwan, Philip Christopher 2004. Evaluation of survival and ischaemic and thromboembolic event rates in patients with nonvalvularatrial fibrillation in the general population when treated and untreated with warfarin [Abstract]. Value in Health 7 (6) , p. 638. 10.1016/S1098-3015(10)65637-9

Currie, Craig John, Dixon, S., Conway, P. and McEwan, Philip Christopher 2004. Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United Kingdom [Abstract]. Value in Health 7 (6) , p. 800. 10.1016/S1098-3015(10)66147-5

McEwan, Philip Christopher, Jones, M., Farina, C. and Currie, Craig John 2004. Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom [Abstract]. Value in Health 7 (6) , p. 721. 10.1016/S1098-3015(10)65900-1

Currie, Craig John, Peters, John Redmond, Morrissey, Malcolm Ivor, Bergenheim, K. and McEwan, Philip Christopher 2004. The impact of vascular events on health-related utility in patients with and without type-2 diabetes [Abstract]. Value in Health 7 (6) , p. 743. 10.1016/S1098-3015(10)65970-0

Currie, Craig John, Morgan, Christopher L., Dixon, Simon, McEwan, Phil, Marchant, Nick, Bearne, Andy, Sharplin, Peter and Peters, John R. 2004. Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death. Diabetes Research and Clinical Practice 65 (3) , pp. 267-274. 10.1016/j.diabres.2004.01.009

Evans, Marc, McEwan, Phil, Peters, John R. and Currie, Craig John 2004. Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate. Diabetes, Obesity and Metabolism 6 (4) , pp. 299-307. 10.1111/j.1462-8902.2004.00340.x

Currie, Craig John, Dixon, S., Morrissey, Malcolm Ivor, Farina, C., Peters, John Redmond and McEwan, Philip Christopher 2004. Evaluation of the association between health-related utility and obesity in hospital treated subjects [Abstract]. Value in Health 7 (3) , p. 331. 10.1016/S1098-3015(10)62409-6

Dixon, S., McEwan, Philip Christopher and Currie, Craig John 2004. Including carer utility in economic evaluations: A preliminary analysis of the implications for funding thresholds [Abstract]. Value in Health 7 (3) , p. 371. 10.1016/S1098-3015(10)62533-8

McEwan, Philip Christopher, Peters, John Redmond, Morrissey, Malcolm Ivor, Bergenheim, K. and Currie, Craig John 2004. Total cholesterol, HDL cholesterol and HbA(1c) affect quality-adjusted life years and hospital costs for patients with type 2 diabetes in the United Kingdom - The Cardiff Diabetes Cost Utility Model [Abstract]. Value in Health 7 (3) , p. 341. 10.1016/S1098-3015(10)62441-2

McEwan, Philip Christopher, Kind, P., Dixon, S. and Currie, Craig John 2004. Using an artificial neural network to predict utility scores from SF-36 data [Abstract]. Value in Health 7 (3) , p. 305. 10.1016/S1098-3015(10)62330-3

Currie, Craig John, Patel, T. C., McEwan, P. and Dixon, S. 2004. Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service. Transfusion Medicine 14 (1) , pp. 19-24. 10.1111/j.0958-7578.2004.00475.x

McEwan, Philip Christopher, Morrissey, Malcolm Ivor and Currie, Craig John 2003. An improved model to calculate utility scores from SF-36 data [Abstract]. Value in Health 6 (3) , pp. 302-303. 10.1016/S1098-3015(10)64108-3

Ahluwalia, Munish, Evans, M., Morris, K., Currie, Craig John, Davies, S., Rees, A. and Thomas, A. 2002. The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naïve patients with type 2 diabetes. Diabetes, Obesity and Metabolism 4 (6) , pp. 376-378. 10.1046/j.1463-1326.2002.00230.x

Bagust, A., Hopkinson, P. K., Maslove, L. and Currie, Craig John 2002. The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060. Diabetic Medicine 19 (s4) , pp. 1-5. 10.1046/j.1464-5491.19.s4.2.x

McEwan, P., Currie, Craig John, Conway, P., Peters, J. R., Dixon, S. and Baboolal, K. 2002. The epidemiology of renal transplantation over 34-years to 2000 in Cardiff in people with and without diabetes: A retrospective analysis. Diabetes 51 , A217-A217.

Currie, Craig John, Morgan, Christopher Llewellyn, Dixon, Simon, McEwan, Philip Christopher, Marchant, N., Bearne, A., Sharplin, P. and Peters, John Redmond 2002. The financial costs of hospital care for people with and without diabetes prior to mortality in the United Kingdom [Abstract]. Diabetes 51 (Sup.2) , A272.

Currie, Craig John, McEwan, Philip Christopher, Dixon, Simon, Morgan, Christopher Llewellyn, Bearne, Andy, Marchant, Nick, Sharplin, Peter and Peters, John Redmond 2002. The financial costs of hospital care for people who have single and multiple macrovascular complications [Abstract]. Diabetes 51 (Sup.2) , A271-A272.

Bagust, A., Hopkinson, P. K., Maier, W. and Currie, Craig John 2001. An economic model of the long-term health care burden of Type II diabetes. Diabetologia 44 (12) , pp. 2140-2155. 10.1007/s001250100023

Cockcroft, J. R., McEwan, P., Evans, L. M., Hopkinson, P., Peters, J. R. and Currie, Craig John 2001. Pulse pressure predicts the risk of cardiovascular events in a large cohort of patients with type 2 diabetes [Abstract]. Diabetologia 44 (S1) , A46-A46. 10.1007/BF03180172

Currie, Craig John, McEwan, P., Hopkinson, P. and Peters, J. R. 2001. The relationship between cardiovascular risk and hospital bed utilisation in people with Type 2 diabetes [Abstract]. Diabetologia 44 (S1) , A253-A253. 10.1007/BF03180172

McEwan, P., Bagust, A., Hopkinson, P., Peters, J. R. and Currie, Craig John 2001. The validity of the UKPDS risk equation for predicting the likelihood of cardiovascular heart disease events in Type 2 diabetes [Abstract]. Diabetologia 44 (S1) , A253-A253. 10.1007/BF03180172

Bagust, A., Hopkinson, P. K., Mera, R., Bakst, A. W. and Currie, Craig 2001. Type 2 diabetes impact on quality-adjusted life expectancy [Abstract]. Diabetologia 44 (1) , A253-A253. 10.1007/BF03180172

Currie, Craig John, McEwan, P., Evans, M., Davies, S., Rees, A. E., Scanlon, M. F., Cockroft, J. R. and Peters, J. R. 2001. An epidemiological association between dyslipidaemia and cerebrovascular events in patients with type 2 diabetes [Abstract]. Diabetes 50 , A151-A151.

Evans, M., McEwan, P., Currie, Craig John, Davies, S., Rees, A. E., Scanlon, M. F., Cockroft, J. R. and Peters, J. R. 2001. Dyslipideamia is predictive of macrovascular events in type 2 diabetes while glyceamia is not [Abstract]. Diabetes 50 , A457-A457.

Rees, A. E., McEwan, P., Davies, S., Evans, M., Scanlon, M. F., Currie, Craig John, Peters, J. R. and Abou-Donia, M. M. 2001. Proxies for insulin resistance are associated with dyslipidaemia in a randomized controlled trial of farglitazar [Abstract]. Diabetes 50 , A520-A520.

Cockroft, J. R., Evans, M., McEwan, P., Currie, Craig John, Davies, S., Rees, A. E., Wilkinson, I. B., Scanlon, M. F. and Peters, J. R. 2001. Pulse pressure predicts the risk of cardiovascular events in a large cohort of patients with type 2 diabetes [Abstract]. Diabetes 50 , A150-A150.

McEwan, P., Williams, J., Griffiths, J., Bagust, A., Peters, J. R., Hopkinson, P. and Currie, Craig John 2001. The Cardiff type 2 diabetes coronary heart disease risk function [Abstract]. Diabetes 50 , A461-A461.

Morgan, Christopher L., Currie, Craig John. and Peters, J. R. 2001. Estimating the prevalence of diagnosed diabetes in a health district of Wales [Letter]. Diabetic Medicine 18 (5) , p. 423. 10.1046/j.1464-5491.2001.00476.x

Davies, M., Dixon, S., Currie, Craig John, Davis, R. E. and Peters, J. R. 2001. Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial. Diabetic Medicine 18 (4) , pp. 301-307. 10.1046/j.1464-5491.2001.00470.x

Dixon, S., Currie, Craig John and Peters, J. R. 2000. The cost of diabetes: time for a different approach? [Guest editorial]. Diabetic Medicine 17 (12) , pp. 820-822. 10.1046/j.1464-5491.2000.00391.x

McEwan, P., Currie, Craig John, Peters, J. R., Hopkinson, P., Griffiths, J. D. and Williams, J. E. 2000. Evaluating the Framingham risk equations for predicting heart disease (CHD) in type 2 diabetes. Diabetologia 43 , A281-A281.

Bagust, A., Hopkinson, P. K. and Currie, Craig John 2000. Future prevalence and economic burden of Type 2 diabetes in the UK. Diabetologia 43 , A233-A233.

Hopkinson, P. K., Bagust, A. and Currie, Craig John 2000. Simulation of lifetime benefits from improved glycaemic control in Type 2 diabetes [Abstract]. Diabetologia 43 , A231-A231.

Morgan, Christopher L., Currie, Craig John and Peters, J. R. 2000. Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23 (8) , pp. 1103-1107. 10.2337/diacare.23.8.1103

McEwan, P. C., Peters, J., Currie, Craig John, Hopkinson, P., Griffiths, J. D. and Williams, J. E. 2000. Association between forms of macro-vascular disease in diabetes and patterns of modifiable risk factors [Abstract]. Diabetes 49 , A389-a389.

Bagust, A., Hummel, S. R., Evans, M., McEwan, P., Hopkinson, P. and Currie, Craig John 2000. Modelling treatment effects on lifetime complications of Type 2 diabetes [Abstract]. Diabetes 49 , A403-A403.

McEwan, P. C., Peters, J., Currie, Craig John, Hopkinson, P., Griffiths, J. D. and Williams, J. E. 2000. The unreliability of Framingham risk equations in predicting coronary heart disease (CHD) events in diabetes [Abstract]. Diabetes 49 , A187-A187.

Morgan, Christopher L., Currie, Craig John, Hunt, J., Evans, J. D., Rogers, C., Stott, N. C. H. and Peters, J. R. 2000. Relative activity and referral patterns for diabetes and non-diabetes in general practice. Diabetic Medicine 17 (3) , pp. 230-235. 10.1046/j.1464-5491.2000.00208.x

Currie, Craig John and MacDonald, Tom M. 2000. Use of routine healthcare data in safe and cost-effective drug use. Drug Safety 22 (2) , pp. 97-102. 10.2165/00002018-200022020-00002

Hopkinson, P. K., Bagust, A., Maier, W. and Currie, Craig John 1999. Long-term complications of type 2 diabetes: Preliminary results from a new economic model [Abstract]. Diabetologia 42 , A249-A249.

Currie, Craig John, Lacey, L. A. and Peters, J. R. 1999. Changes in glucose tolerance at high altitude [Abstract]. Diabetes 48 , A399-A400.

McCaul, K., Nevill, T. J., Klingemann, H. G., Nantel, S. H., Toze, C. L., Sutherland, H. J., Conneally, E. A., Shepherd, J. D., Hogge, D. E., Currie, Craig John and Barnett, M. J. 1998. Treatment of steroid-resistant graft-versus-host disease (GVHD) following allogeneic bone marrow transplantation (BMT) with rabbit anti-thymocyte globulin (ATG)[Abstract]. Blood 92 (10) , 335B-335B.

Currie, Craig John and Peters, John R. 1998. The demand and financial cost of hospital care for diabetes mellitus and its related complications [Guest editorial]. Diabetic Medicine 15 (6) , pp. 449-451. 10.1002/(SICI)1096-9136(199806)15:6<449::AID-DIA629>3.0.CO;2-Z

Currie, Craig John 1998. Regional clearing for biomedical manuscripts [Correspondence]. The Lancet 351 (9114) , p. 1518. 10.1016/S0140-6736(05)78916-9

Currie, Craig John, Morgan, Christopher L., Peters, John R. and Kerr, Michael Patrick 1998. The demand for hospital services for patients with epilepsy. Epilepsia 39 (5) , pp. 537-544. 10.1111/j.1528-1157.1998.tb01417.x

Morgan, C. L., Davies, S., Green, J. T. and Currie, Craig John 1998. Emergency care outside hospital [Letter]. Hospital Medicine 59 (3) , p. 249.

Morgan, C. L., Currie, Craig John, Green, J. and Davies, S. 1998. Acute work injuries among electric utility meter readers [letter]. Epidemiology 9 (1) , p. 108. 10.1097/00001648-199801000-00023

Currie, Craig John, Morgan, Christopher L. and Peters, John R. 1998. The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes. Diabetes Care 21 (1) , pp. 42-48. 10.2337/diacare.21.1.42

Davies, J. S., Green, J. and Currie, Craig John 1997. Carcinoid tumours [Letter]. Postgraduate Medical Journal -London- 73 (866) , p. 836. 10.1136/pgmj.73.866.836

Davies, J. S., Morgan, Christopher L., Currie, Craig John and Green, J. T. 1997. Growth hormone use by body builders [Letter]. British Journal of Sports Medicine 31 (4) , pp. 352-353. 10.1136/bjsm.31.4.352-b

Currie, Craig John, Morgan, Christopher L. and Peters, J. R. 1997. Patterns and costs of hospital care for coronary heart disease related and not related to diabetes. Heart 78 (6) , pp. 544-549. 10.1136/hrt.78.6.544

Currie, Craig, Green, J., Davies, S. and Morgan, C. 1997. Cost effectiveness of medical ethics training. Journal of Medical Ethics 23 (5) , p. 328. 10.1136/jme.23.5.328-a

Hanna, F. W. F., Currie, Craig John, Morgan, C. L., Peters, J. R. and Rees, A. 1997. Risk of macrovascular complications in diabetes: Comparison of the influence of gender on ischaemic heart disease and cerebrovascular disease [Abstract]. Atherosclerosis 134 (1-2) , p. 309. 10.1016/S0021-9150(97)89588-3

Green, J., Davies, S., Currie, Craig John and Morgan, C. 1997. Koch's or Crohn's - or something else? [letter]. International Journal of Clinical Practice 51 (7) , p. 480.

Currie, Craig John 1997. Author saw fraud, misconduct, and unfairness to more junior staff. BMJ 315 (7110) , pp. 747-748.

Green, J. and Currie, Craig 1997. The course of alcohol withdrawal in a general hospital. QJM: An International Journal of Medicine 90 (8) , p. 552. 10.1093/qjmed/90.8.552

Currie, Craig John, Kraus, D., Morgan, Christopher L., Gill, L., Stott, N. C. H. and Peters, J. R. 1997. NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabetic Medicine 14 (8) , pp. 686-692. 10.1002/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.0.CO;2-D

Doyle, Y., Hayward, P., Madden, M., Watts, B and Currie, Craig 1997. Continuing professional development in public health medicine. Journal of the Royal College of Physicians 31 (4) , pp. 405-409.

Morgan, Christopher L., Currie, Craig John and Peters, John R. 1997. Hospital utilization as a function of social deprivation: diabetes vs non-diabetes. Diabetic Medicine 14 (7) , pp. 589-594. 10.1002/(SICI)1096-9136(199707)14:7<589::AID-DIA391>3.0.CO;2-H

Currie, Craig John, Morgan, Christopher L., Gill, Leicester, Stott, Nigel C. H. and Peters, John R. 1997. Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 28 (6) , pp. 1142-1146. 10.1161/01.STR.28.6.1142

Hanna, F. W., Currie, Craig John, Morgan, C. L., Rees, A. and Peters, J. R. 1997. Gender influence of macrovascular disease in diabetes [Abstract]. Diabetologia 40 (S1) , A442-A442. 10.1007/BF03162081

Currie, Craig John and Peters, J. R. 1997. Estimation of unascertained diabetes prevalence: different effects on calculation of complication rates and resource utilization. Diabetic Medicine 14 (6) , pp. 477-481. 10.1002/(SICI)1096-9136(199706)14:6<477::AID-DIA379>3.0.CO;2-9

Currie, Craig John and Peters, J. R. 1997. Sex and coronary heart disease: the relative probability of dying in hospital [Brief report]. Heart 77 (4) , pp. 371-372. 10.1136/hrt.77.4.371

Morgan, C. L., Evans, M., Peters, J. R., Currie, Craig, Mitchison, S., Gissler, M., Hemminki, E. and Lonnqvist, J. 1997. Suicides after pregnancy. BMJ 314 (7084) , p. 902. 10.1136/bmj.314.7084.902

Hanna, F. W. F., Currie, Craig John, Rees, A. and Peters, J. R. 1996. Gender difference in the relative risk of ischaemic heart disease in diabetes [Abstract]. Diabetologia 39 (S1) , p. 736.

Currie, Craig and Peters, John 1996. Costs of insulin-dependent diabetes mellitus. Diabetic Medicine 13 (7) , p. 684. 10.1002/(sici)1096-9136(199607)13:7%3C684::aid-dia149%3E3.0.co;2-k

Currie, Craig John, Williams, D. R. R. and Peters, J. R. 1996. Patterns of in and out-patient activity for diabetes: a district survey. Diabetic Medicine 13 (3) , pp. 273-280. 10.1002/(SICI)1096-9136(199603)13:3<273::AID-DIA57>3.0.CO;2-S

Bagust, A., Morgan, C. Ll., Currie, Craig John, Hopkinson, P. and Peters, J. R. Estimating the excess costs of health care due to type 2 diabetes in the UK [Abstract]. Diabetes 49 , A215-A215.

This list was generated on Fri Sep 22 11:09:10 2017 BST.